Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vaxcyte (PCVX) Change in Account Payables (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Change in Account Payables data on record, last reported at -$269000.0 in Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 99.08% to -$269000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $48.8 million, a 19542.23% increase, with the full-year FY2025 number at $19.9 million, down 42.44% from a year prior.
  • Change in Account Payables reached -$269000.0 in Q1 2026 per PCVX's latest filing, down from $21.7 million in the prior quarter.
  • Over the last five years, Change in Account Payables for PCVX hit a ceiling of $31.3 million in Q4 2024 and a floor of -$29.2 million in Q1 2025.
  • A 5-year average of $4.0 million and a median of $2.7 million in 2022 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: skyrocketed 1097.55% in 2024, then tumbled 614.16% in 2025.
  • Tracing PCVX's Change in Account Payables over 5 years: stood at $3.5 million in 2022, then soared by 86.66% to $6.5 million in 2023, then surged by 383.24% to $31.3 million in 2024, then crashed by 30.8% to $21.7 million in 2025, then plummeted by 101.24% to -$269000.0 in 2026.
  • Business Quant data shows Change in Account Payables for PCVX at -$269000.0 in Q1 2026, $21.7 million in Q4 2025, and $17.9 million in Q3 2025.